Charles Schwab’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.59M | Buy |
|
|||||
|
2025
Q1 | $11.5M | Sell |
|
|||||
|
2024
Q4 | $14.3M | Buy |
|
|||||
|
2024
Q3 | $13.9M | Sell |
|
|||||
|
2024
Q2 | $10.3M | Buy |
|
|||||
|
2024
Q1 | $9.07M | Buy |
|
|||||
|
2023
Q4 | $3.62M | Buy |
|
|||||
|
2023
Q3 | $1.9M | Buy |
|
|||||
|
2023
Q2 | $2.41M | Buy |
|
|||||
|
2023
Q1 | $1.96M | Sell |
|
|||||
|
2022
Q4 | $2.65M | Buy |
|
|||||
|
2022
Q3 | $2M | Buy |
|
|||||
|
2022
Q2 | $918K | Sell |
|
|||||
|
2022
Q1 | $1.41M | Buy |
|
|||||
|
2021
Q4 | $2.15M | Buy |
|
|||||
|
2021
Q3 | $1.4M | Buy |
|
|||||
|
2021
Q2 | $1.73M | Buy |
|